Overall, our results showed that the canonical Hippo pathway was aberrantly activated both in vivo and in vitro models of nphp1 deficiency, as well as in the kidneys of human NPH1 patients, and was highly active in renal cyst cells. The gene discussed is NPHP1; the disease is cystic kidney disease.